Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedJan 30, 2025
DataAggregated Company Financials
Companies18
  • 7D2.1%
  • 3M1.6%
  • 1Y2.4%
  • YTDn/a

The Pharma industry is up 1.3% in the last week, with AstraZeneca up 1.7%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 30 Jan 2025UK£239.2bUK£75.8bUK£7.8b33.3x30.5x3.2x
Sat, 28 Dec 2024UK£224.3bUK£75.3bUK£7.8b31.4x28.8x3x
Mon, 25 Nov 2024UK£224.7bUK£75.5bUK£7.8b31.3x28.8x3x
Wed, 23 Oct 2024UK£251.3bUK£72.5bUK£9.1b30.5x27.7x3.5x
Fri, 20 Sep 2024UK£256.1bUK£71.6bUK£8.9b38x28.6x3.6x
Sun, 18 Aug 2024UK£275.1bUK£72.6bUK£9.0b40.7x30.4x3.8x
Tue, 16 Jul 2024UK£256.3bUK£70.7bUK£9.4b32.4x27.1x3.6x
Thu, 13 Jun 2024UK£265.5bUK£71.2bUK£9.5b30.4x27.8x3.7x
Sat, 11 May 2024UK£273.5bUK£72.1bUK£9.6b37.4x28.4x3.8x
Mon, 08 Apr 2024UK£240.7bUK£70.8bUK£9.7b31.4x24.8x3.4x
Wed, 06 Mar 2024UK£234.3bUK£70.5bUK£9.7b30.8x24.1x3.3x
Fri, 02 Feb 2024UK£237.2bUK£69.5bUK£9.5b35.9x25x3.4x
Sun, 31 Dec 2023UK£235.0bUK£68.8bUK£10.7b35.5x22.1x3.4x
Tue, 28 Nov 2023UK£224.2bUK£69.2bUK£10.7b53.6x20.9x3.2x
Thu, 26 Oct 2023UK£237.7bUK£70.8bUK£10.4b55x22.9x3.4x
Sat, 23 Sep 2023UK£247.9bUK£70.4bUK£10.3b56.6x24x3.5x
Mon, 21 Aug 2023UK£234.0bUK£68.9bUK£10.2b53.5x23x3.4x
Wed, 19 Jul 2023UK£226.8bUK£66.8bUK£7.8b52x29.1x3.4x
Fri, 16 Jun 2023UK£250.6bUK£67.6bUK£7.9b55.5x31.8x3.7x
Sun, 14 May 2023UK£259.2bUK£68.6bUK£8.0b59.3x32.5x3.8x
Tue, 11 Apr 2023UK£254.7bUK£69.3bUK£6.9b50.5x37.1x3.7x
Thu, 09 Mar 2023UK£237.3bUK£71.2bUK£7.0b49.7x33.9x3.3x
Sat, 04 Feb 2023UK£236.0bUK£71.1bUK£6.3b38.1x37.2x3.3x
Mon, 02 Jan 2023UK£244.5bUK£80.1bUK£6.3b37.3x38.6x3.1x
Wed, 30 Nov 2022UK£240.3bUK£80.4bUK£6.4b36.6x37.8x3x
Fri, 28 Oct 2022UK£220.7bUK£79.6bUK£3.7b21.5x59.7x2.8x
Sun, 25 Sep 2022UK£218.6bUK£82.1bUK£3.6b13.8x59.9x2.7x
Tue, 23 Aug 2022UK£247.6bUK£79.0bUK£3.7b14.7x66.3x3.1x
Thu, 21 Jul 2022UK£282.3bUK£75.3bUK£4.6b14.5x61.7x3.7x
Sat, 18 Jun 2022UK£250.9bUK£74.6bUK£4.6b15.7x55x3.4x
Mon, 16 May 2022UK£260.9bUK£74.5bUK£4.6b16.3x57.1x3.5x
Wed, 13 Apr 2022UK£268.6bUK£66.7bUK£4.8b20.6x55.9x4x
Fri, 11 Mar 2022UK£235.7bUK£66.7bUK£4.7b24.5x49.7x3.5x
Sun, 06 Feb 2022UK£226.5bUK£61.3bUK£5.6b32.3x40.2x3.7x
Price to Earnings Ratio

40.2x


Total Market Cap: UK£226.5bTotal Earnings: UK£5.6bTotal Revenue: UK£61.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 37.5x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 30.4x which is lower than its 3-year average PE of 37.5x.
  • The industry is trading close to its 3-year average PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 7.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.K. Pharma compare with similar industries?

GB Market0.14%
Healthcare1.91%
Pharma2.11%
Pharma2.11%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£112.321.7%
+UK£3.0b		7.0%PE33.3x
GSK GSKUK£14.013.3%
+UK£1.8b		-10.7%PE22.8x
HIK Hikma PharmaceuticalsUK£22.485.5%
+UK£261.7m		16.4%PE21.7x
IMM ImmuPharmaUK£0.04972.5%
+UK£8.6m		265.7%PB7.6x
POLB Poolbeg PharmaUK£0.05210.6%
+UK£2.5m		-37.7%PB2.1x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

INDV

UK£9.72

Indivior

7D

-0.1%

1Y

-29.9%

AGY

UK£0.065

Allergy Therapeutics

7D

-12.4%

1Y

225.0%

AZN

UK£112.32

AstraZeneca

7D

1.7%

1Y

7.0%

GSK

UK£14.01

GSK

7D

3.3%

1Y

-10.7%

STX

UK£0.027

Shield Therapeutics

7D

11.3%

1Y

-57.5%

IMM

UK£0.049

ImmuPharma

7D

72.5%

1Y

265.7%

Is ImmuPharma (LON:IMM) In A Good Position To Deliver On Growth Plans?

Jan 25
Is ImmuPharma (LON:IMM) In A Good Position To Deliver On Growth Plans?

APH

UK£0.61

Alliance Pharma

7D

-0.2%

1Y

62.7%

HCM

UK£2.21

HUTCHMED (China)

7D

-4.9%

1Y

12.4%

POLB

UK£0.052

Poolbeg Pharma

7D

10.6%

1Y

-37.7%

SAR

UK£0.21

Sareum Holdings

7D

-8.7%

1Y

-54.8%

HIK

UK£22.48

Hikma Pharmaceuticals

7D

5.5%

1Y

16.4%

ANCR

UK£2.43

Animalcare Group

7D

1.3%

1Y

36.9%

EAH

UK£0.65

ECO Animal Health Group

7D

3.2%

1Y

-40.3%

CEL

UK£0.20

Celadon Pharmaceuticals

7D

-5.1%

1Y

-76.3%